BridgeMD
New treatment option for Rhinitis Acute
Official title RhinAV_Evaluation of Treatments for Acute Viral Rhinitis, Rhinosinusitis, and Rhinopharyngitis
ClinicalTrials.gov ID: NCT07383493
What this study is testing
- What it's testing
- The objective of this study is to conduct post-marketing clinical follow-up of four products: NS, NHE, NHG, and PIR. This follow-up will consist of collecting clinical data in real-life conditions to confirm the tolerance, safety, and efficacy of medical devices used in the treatment of acute viral rhinitis, rhinosinusitis, and rhinopharyngitis, while also assessing the benefit/risk ratio of the products.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Acute viral rhinitis or acute rhinosinusitis or viral rhinopharyngitis (sneezing, rhinorrhea, nasal obstruction, cough secondary to posterior...
- Effective contraception for female patients of childbearing age.
- Cooperation and sufficient understanding to comply with the requirements of the trial.
- Acceptance of registration in the SI-RIPH VRB file.
- Having received informed information and agreeing to give written consent.
You likely can't join if
- Hypersensitivity/history of allergy to any of the product's components,
- Complicated rhinitis, rhinosinusitis, or rhinopharyngitis (acute bacterial sinusitis, acute otitis media, acute bronchitis, or pneumonia) or severe...
- Chronic rhinosinusitis,
- Allergic rhinosinusitis,
- Other ongoing treatments for acute rhinitis (local treatment, antitussives, antibiotics, antiretrovirals, corticosteroids, etc.),
- Positive antigen test for influenza A/B or COVID-19 and infection requiring etiological treatment according to the recommendations,
See the full eligibility criteria
- Acute viral rhinitis or acute rhinosinusitis or viral rhinopharyngitis (sneezing, rhinorrhea, nasal obstruction, cough secondary to posterior rhinorrhea, sore throat) that began less than 72 hours prior to the inclusion...
- Effective contraception for female patients of childbearing age.
- Cooperation and sufficient understanding to comply with the requirements of the trial.
- Acceptance of registration in the SI-RIPH VRB file.
- Having received informed information and agreeing to give written consent.
- Affiliated with the French Social Security system.
- Hypersensitivity/history of allergy to any of the product's components,
- Complicated rhinitis, rhinosinusitis, or rhinopharyngitis (acute bacterial sinusitis, acute otitis media, acute bronchitis, or pneumonia) or severe cough that is poorly tolerated,
- Chronic rhinosinusitis,
- Allergic rhinosinusitis,
- Other ongoing treatments for acute rhinitis (local treatment, antitussives, antibiotics, antiretrovirals, corticosteroids, etc.),
- Positive antigen test for influenza A/B or COVID-19 and infection requiring etiological treatment according to the recommendations,
- Bacterial rhinopharyngitis with positive TROD test
- Comorbidities or health conditions deemed incompatible with the trial by the investigator,
- Recent ENT surgery (\<6 months),
- ENT pathology such as nasal septum deviation or other causes of nasal obstruction,
- Pulmonary pathology (COPD, asthma, etc.),
- Immunosuppression (as reported by the patient),
- Pregnant or breastfeeding women,
- Currently participating in another clinical trial, or in the exclusion period, or having received total compensation of more than €6,000 in the 12 months prior to the start of the trial,
- Benefiting from legal protection measures (guardianship, trusteeship, deprivation of liberty, judicial protection).
The study team makes the final eligibility decision.
Where it's taking place
- Clermont-Ferrand, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Clermont-Ferrand, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.